A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A106.4 KBAMYRIS, INC.May 7, 7:49 PM ET·0001193125-24-133435
- 8-K158.4 KBAMYRIS, INC.May 7, 2:39 PM ET·0001193125-24-132953
- 8-K149.9 KBAMYRIS, INC.Apr 23, 4:01 PM ET·0001193125-24-106956
- 8-K151.8 KBAMYRIS, INC.Apr 8, 4:06 PM ET·0001193125-24-089614
- 8-K75.4 MBAMYRIS, INC.Feb 28, 5:19 PM ET·0001365916-24-000011
- 8-K1.6 MBAMYRIS, INC.Feb 9, 4:42 PM ET·0001365916-24-000008
- SC 13D/A124.4 KBAMYRIS, INC.Jan 5, 4:22 PM ET·0001193125-24-003393
- 8-K284.5 KBAMYRIS, INC.Jan 4, 4:35 PM ET·0001365916-24-000003
- 8-K89.4 MBAMYRIS, INC.Dec 29, 4:09 PM ET·0001365916-23-000151
- 8-K176.9 KBAMYRIS, INC.Dec 27, 4:08 PM ET·0001365916-23-000149
Insiders
10- Alexander RalphDirector
- Al Thani Sheikh Abdullah bin KhalifaDirector
- ALVAREZ EDUARDOChief Operating Officer
- ASADORIAN RAFFIChief Financial Officer
- Boisseau PhilippeDirector, 10% Owner
- Boynton PeterChief Commercial Officer
- Canhill Investments Pte. Ltd.10% Owner
- Cherry JoelSVP, Res. Progs. & Ops.
- CHUA NAM HAI DRDirector
- Diniz Paulo Sergio de OliveiraCEO, Amyris Brasil S.A.
Tickers
No tickers on record
Addresses
business
5885 HOLLIS STREET, SUITE 100
EMERYVILLE, CA, 94608
mailing
5885 HOLLIS STREET, SUITE 100
EMERYVILLE, CA, 94608
Former Names
- AMYRIS BIOTECHNOLOGIES INC2010-05-25